Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

NCT02096341 is registered in ClinicalTrials.gov with EpicentRx, Inc. as lead sponsor.

NCT NCT02096341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02096341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001
Lead sponsor
EpicentRx, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2014
Completion date
January 31, 2016
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphomas, malignant solid tumor